Publication | Open Access
Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
235
Citations
16
References
2009
Year
IV VEGF Trap was well tolerated at the dose levels tested. Pharmacodynamic and pharmacokinetic markers were indicative of VEGF blockade.
| Year | Citations | |
|---|---|---|
Page 1
Page 1